Systemic Inflammation and Subclinical Hepatic Synthetic Dysfunction Following Doxorubicin-Cyclophosphamide Chemotherapy in Ethiopian Women With Breast Cancer: A Prospective Cohort Study.

Nida T, Bedada AT

Open source

DOI
10.1002/hsr2.73236
Published
2026 Sep
Container
Health science reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hsr2.73236,
  title = {Systemic Inflammation and Subclinical Hepatic Synthetic Dysfunction Following Doxorubicin-Cyclophosphamide Chemotherapy in Ethiopian Women With Breast Cancer: A Prospective Cohort Study.},
  author = {Nida T and Bedada AT},
  year = {2026},
  journal = {Health science reports},
  doi = {10.1002/hsr2.73236},
  url = {https://doi.org/10.1002/hsr2.73236}
}

RIS

TY  - JOUR
TI  - Systemic Inflammation and Subclinical Hepatic Synthetic Dysfunction Following Doxorubicin-Cyclophosphamide Chemotherapy in Ethiopian Women With Breast Cancer: A Prospective Cohort Study.
AU  - Nida T
AU  - Bedada AT
PY  - 2026
JO  - Health science reports
DO  - 10.1002/hsr2.73236
UR  - https://doi.org/10.1002/hsr2.73236
ER  - 

APA

T, N., & AT, B. (2026). Systemic Inflammation and Subclinical Hepatic Synthetic Dysfunction Following Doxorubicin-Cyclophosphamide Chemotherapy in Ethiopian Women With Breast Cancer: A Prospective Cohort Study.. Health science reports. https://doi.org/10.1002/hsr2.73236

Source records